CXCR4/CXCR7 Blockade and Treatment of Human Papilloma Virus-Associated Disease

• 收藏
• 分享

专利权人:

The General Hospital Corporation

发明人:

Mark C. Poznansky,Jeffrey Gelfand,Sara Pai

申请号：

US16496821

公开号：

US20200030286A1

申请日:

2018.03.22

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to methods and compositions for treating human papilloma virus (HPV)-associated diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for treating immune checkpoint blockade resistant diseases using an inhibitor of CXCL12 signaling. The invention further relates to methods and compositions for enhancing the immune response against an HPV-associated disease using an inhibitor of CXCL12 signaling.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/